Bryan Kay
Carotid endarterectomy associated with less reintervention than stenting in first six...
A durability study that looks at reintervention risk among patients treated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS) procedures established that CEA...
Endarterectomy and TCAR ‘continue to show superior outcomes’ to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularisation, with CEA and transcarotid...
Female sex “should be considered an independent risk factor” for new...
A preliminary report lends evidence to support female sex being considered as an independent risk factor for new stroke occurrence after carotid revascularisation in...
Increased market competition linked to higher odds of revascularisation among asymptomatic...
A vascular surgery research team with a growing reputation for its work investigating appropriateness in care in the peripheral vascular bed recently uncovered an...
TCAR yields “high technical success, with an extraordinarily low stroke and...
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularisation (TCAR; Silk Road Medical) treatment for carotid stenosis...
Study detects no difference in adverse outcomes from balloon dilatation strategy...
Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularisation (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery...
Study shows novel AI technology is better predictor of stroke than...
Boston-based medical technology company Elucid Bio, maker of the Food and Drug Administration (FDA)-cleared and CE-marked vascuCAP software, announced Wednesday, July 1, that its...
